Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacology and Therapeutic Potential of the 5-HT7 Receptor
Kevin M. Blattner, Daniel J. Canney, Douglas A. Pippin, et al.
ACS Chemical Neuroscience (2018) Vol. 10, Iss. 1, pp. 89-119
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

The Roles of Serotonin in Neuropsychiatric Disorders
Mahsa Pourhamzeh, Fahimeh Ghasemi Moravej, Mehrnoosh Arabi, et al.
Cellular and Molecular Neurobiology (2021) Vol. 42, Iss. 6, pp. 1671-1692
Closed Access | Times Cited: 216
Central 5-HT receptors and their function; present and future
Trevor Sharp, Nicholas M. Barnes
Neuropharmacology (2020) Vol. 177, pp. 108155-108155
Open Access | Times Cited: 160
Serotonin receptors in epilepsy: Novel treatment targets?
Jo Sourbron, Lieven Lagae
Epilepsia Open (2022) Vol. 7, Iss. 2, pp. 231-246
Open Access | Times Cited: 40
Role of the Serotonin Receptor 7 in Brain Plasticity: From Development to Disease
Marianna Crispino, Floriana Volpicelli, Carla Perrone‐Capano
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 505-505
Open Access | Times Cited: 52
Rewiring of the Serotonin System in Major Depression
Faranak Vahid-Ansari, Paul R. Albert
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 51
Functional Dimerization of Serotonin Receptors: Role in Health and Depressive Disorders
Еlena V. Mitroshina, Ekaterina A. Marasanova, Maria V. Vedunova
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16416-16416
Open Access | Times Cited: 18
Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy
Ruri Okubo, Toshiki Hasegawa, Kouji Fukuyama, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 39
Therapeutic Potential and Limitation of Serotonin Type 7 Receptor Modulation
Kouji Fukuyama, Eishi Motomura, Motohiro Okada
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2070-2070
Open Access | Times Cited: 15
5-HT Receptors and Temperature Homeostasis
I. P. Voronova
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1914-1914
Open Access | Times Cited: 31
Aporphines: A privileged scaffold in CNS drug discovery
Rongfeng Zhu, Guangqian Jiang, Wanyu Tang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115414-115414
Closed Access | Times Cited: 12
5-HT7 receptor-dependent intestinal neurite outgrowth contributes to visceral hypersensitivity in irritable bowel syndrome
Wen-Ying Chang, Yi-Ting Yang, Meng‐Ping She, et al.
Laboratory Investigation (2022) Vol. 102, Iss. 9, pp. 1023-1037
Open Access | Times Cited: 18
Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders
Radomír Jůza, Kamil Musílek, Eva Mezeiová, et al.
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 55-211
Closed Access | Times Cited: 17
Unlocking the Mysteries: Serotonin Receptor Networks Explored
Javeria Tanveer, Ammarah Baig, Rukhsana Rubeen, et al.
IntechOpen eBooks (2024)
Open Access | Times Cited: 3
Fluorinated indole-imidazole conjugates: Selective orally bioavailable 5-HT7 receptor low-basicity agonists, potential neuropathic painkillers
Adam S. Hogendorf, Agata Hogendorf, Katarzyna Popiołek-Barczyk, et al.
European Journal of Medicinal Chemistry (2019) Vol. 170, pp. 261-275
Closed Access | Times Cited: 28
Design, synthesis, and biological evaluation of aralkyl piperazine and piperidine derivatives targeting SSRI/5-HT1A/5-HT7
Jianwei Wu, Zixue Zhang, Qingwei Zhang, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 104, pp. 117698-117698
Closed Access | Times Cited: 2
Novel thienocycloalkylpyridazinones as useful scaffolds for acetylcholinesterase inhibition and serotonin 5-HT6 receptor interaction
Battistina Asproni, Marco Catto, Giovanni Loriga, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 84, pp. 117256-117256
Open Access | Times Cited: 6
Isoquinolinone derivatives as potent CNS multi-receptor D2/5-HT1A/5-HT2A/5-HT6/5-HT7 agents: Synthesis and pharmacological evaluation
Jian Jin, Kun-Xiao Zhang, Fei Dou, et al.
European Journal of Medicinal Chemistry (2020) Vol. 207, pp. 112709-112709
Closed Access | Times Cited: 14
Design and synthesis of new potent 5-HT7 receptor ligands as a candidate for the treatment of central nervous system diseases
Damian Kułaga, Anna K. Drabczyk, Grzegorz Satała, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113931-113931
Closed Access | Times Cited: 12
Novel D2/5-HT receptor modulators related to cariprazine with potential implication to schizophrenia treatment
Radomír Jůza, Iveta Vojtěchová, Kristýna Štefková, et al.
European Journal of Medicinal Chemistry (2022) Vol. 232, pp. 114193-114193
Closed Access | Times Cited: 8
Benzoxazolone‐arylpiperazinyl scaffold‐based PET ligand for 5‐HT7: Synthesis and biological evaluation
N. Kumari, Anupriya Adhikari, Deepika Singh, et al.
Drug Development Research (2022) Vol. 83, Iss. 4, pp. 1024-1033
Closed Access | Times Cited: 8
An adult Drosophila glioma model to highlight metabolic dysfunctions and evaluate the role of the serotonin 5‐HT7 receptor as a potential therapeutic target
Marylène Bertrand, Frédéric Szeremeta, Nadège Hervouet‐Coste, et al.
The FASEB Journal (2023) Vol. 37, Iss. 11
Closed Access | Times Cited: 4
The Importance of Stereochemistry in 5-HT7R Modulation─A Case Study of Hydantoin Derivatives
Katarzyna Kucwaj‐Brysz, Sebastian Baś, Ewa Żesławska, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 21, pp. 3884-3900
Open Access | Times Cited: 1
Antidepressant Drug Discovery and Development: Mechanism and Drug Design Based on Small Molecules
Chuansheng Yao, Xiaoying Jiang, Xiang‐Yang Ye, et al.
Advanced Therapeutics (2022) Vol. 5, Iss. 5
Closed Access | Times Cited: 7
Serodolin, a β-arrestin–biased ligand of 5-HT 7 receptor, attenuates pain-related behaviors
Chayma El Khamlichi, Flora Reverchon, Nadège Hervouet‐Coste, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 21
Open Access | Times Cited: 7
Synthesis and Biological Evaluation of 99mTc-Labeled Phenylpiperazine Derivatives as Selective Serotonin-7 Receptor Ligands for Brain Tumor Imaging
Shahnaz Saednia, Saeed Emami, Sajjad Molavipordanjani, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 6, pp. 2360-2374
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top